The stocks of JNJ will be covered by analysts working at Morgan Stanley which was published in a Friday research report. Currently, the brokerage has put up a rating of overweight on the company with a price target of $187 on the stock. The price target set by the brokerage indicates an increase of 10.78% from the current price of the company.
The Quarterly Estimates of JNJ
The stocks of JNJ traded on Friday at $168.81 in the stock market. The moving average price of the company over a period of 50 days is $166.07, with the moving average price of the company over a period of 200 days set at $159.66. The market cap of the company stands at $444.54 billion, with a 29.83 PE ratio, along with a 2.71 PEG ratio, and a 0.71 beta. The year low of the company is $133.65, with a year high set at $173.65. The current ratio of the company is 1.28, with a 1.04 quick ratio.
JNJ previously released its quarterly reports on the 19th of April. The EPS reported by the company during this period was $2.59, which was more than the consensus estimate of $2.34. The revenue generated by the company during this period was $22.30 billion, which was more than the consensus estimate of $22 billion. The net margin of the company is 17.95%, with a 34.62% return on equity.
There have been quite a few hedge funds and institutional investors that have already increased their stakes in the stocks of JNJ. Bluesphere Advisors LLC has increased its holding in the company by 2.3% in the first quarter. The LLC now has ownership of 2,593 shares of the company at a valuation of $426,000 after purchasing another 59 shares in the same period.